Relative to IUD pain management coverage
This bill requires health coverage for pain control methods used during intrauterine device (IUD) insertion. It specifies that covered methods may include intravenous sedation, oral sedation, nitrous oxide, local anesthesia, or topical anesthesia, when prescribed by a provider acting within their scope of practice. The bill applies across several major coverage categories in Massachusetts, including the Group Insurance Commission for state employees and retirees, Medicaid and Medicaid managed care arrangements, individual and group accident and sickness insurance, hospital service plans, medical service agreements, and health maintenance contracts.
The bill also bars cost-sharing for the covered pain management services, subject only to limited exceptions already recognized under federal law or existing statutory carve-outs. It further requires that coverage not be subject to unreasonable restrictions or delays, while allowing reasonable medical management within an FDA-defined method category. For employer-sponsored plans, the bill includes religious exemptions for churches and qualified church-controlled organizations, along with notice requirements to enrollees when those exemptions are used.
If enacted, the bill would amend multiple chapters of the Massachusetts General Laws governing public employee insurance, Medicaid, commercial health insurance, hospital service corporations, medical service corporations, and HMOs. It would create a new mandated benefit for IUD insertion pain management and require insurers and public programs to cover those services without deductibles, copayments, or coinsurance in most cases. The bill would affect state agencies, insurers, health plans, and third-party administrators by requiring them to update benefit designs, claims processing, and compliance practices, while preserving existing regulatory oversight by the Division of Insurance, the Division of Medical Assistance, and the Group Insurance Commission.
The available committee action suggests generally favorable sentiment toward the bill. The House Committee on Financial Services reported that the bill ought to pass, indicating support for expanding access to pain management during IUD insertion. No recorded votes or committee transcript excerpts are provided, so there is no evidence in the available materials of organized opposition or divided debate. Overall, the bill appears to have been advanced as a health coverage expansion with broad policy support at the committee level.
The main points of contention likely concern the scope of the mandate and its interaction with insurance regulation, cost-sharing, and religious exemptions. Insurers and plan administrators may view the bill as adding a new required benefit and administrative burden, while supporters would emphasize patient access and reduced pain during IUD procedures. Another potential issue is the bill’s application to public programs and employer plans, including the carve-out for churches and qualified church-controlled organizations, which may draw attention from both religious liberty advocates and reproductive health advocates. The bill also preserves medical management authority, but only within a method category, which could be a point of dispute over how much discretion plans retain.